285 related articles for article (PubMed ID: 11591709)
21. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
23. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
24. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
[TBL] [Abstract][Full Text] [Related]
25. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
26. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
[TBL] [Abstract][Full Text] [Related]
27. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
Maekawa A; Austen KF; Kanaoka Y
J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
[TBL] [Abstract][Full Text] [Related]
28. Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4.
Yang G; Haczku A; Chen H; Martin V; Galczenski H; Tomer Y; Van Besien CR; Evans JF; Panettieri RA; Funk CD
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L992-1001. PubMed ID: 15064240
[TBL] [Abstract][Full Text] [Related]
29. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages.
Thivierge M; Stanková J; Rola-Pleszczynski M
J Immunol; 2001 Sep; 167(5):2855-60. PubMed ID: 11509632
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
31. Cysteinyl leukotriene receptors.
Hui Y; Funk CD
Biochem Pharmacol; 2002 Dec; 64(11):1549-57. PubMed ID: 12429344
[TBL] [Abstract][Full Text] [Related]
32. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
Kamohara M; Takasaki J; Matsumoto M; Matsumoto Si ; Saito T; Soga T; Matsushime H; Furuichi K
Biochem Biophys Res Commun; 2001 Oct; 287(5):1088-92. PubMed ID: 11587533
[TBL] [Abstract][Full Text] [Related]
34. A functional study on CysLT(1) receptors in human eosinophils.
Ohshima N; Nagase H; Koshino T; Miyamasu M; Yamaguchi M; Hirai K; Yamamoto K; Fujisawa T; Nakagawa N; Kishikawa K; Morita Y
Int Arch Allergy Immunol; 2002 Sep; 129(1):67-75. PubMed ID: 12373000
[TBL] [Abstract][Full Text] [Related]
35. Expression of functional cysteinyl leukotriene receptors by human basophils.
Gauvreau GM; Plitt JR; Baatjes A; MacGlashan DW
J Allergy Clin Immunol; 2005 Jul; 116(1):80-7. PubMed ID: 15990778
[TBL] [Abstract][Full Text] [Related]
36. A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate.
Thompson MD; Capra V; Takasaki J; Maresca G; Rovati GE; Slutsky AS; Lilly C; Zamel N; McIntyre Burnham W; Cole DE; Siminovitch KA
Pharmacogenet Genomics; 2007 Jul; 17(7):539-49. PubMed ID: 17558309
[TBL] [Abstract][Full Text] [Related]
37. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.
Austen KF; Maekawa A; Kanaoka Y; Boyce JA
J Allergy Clin Immunol; 2009 Sep; 124(3):406-14; quiz 415-6. PubMed ID: 19647860
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologue.
Boie Y; Stocco R; Sawyer N; Greig GM; Kargman S; Slipetz DM; O'Neill GP; Shimizu T; Yokomizo T; Metters KM; Abramovitz M
Eur J Pharmacol; 1999 Sep; 380(2-3):203-13. PubMed ID: 10513580
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).
Iwasaki T; Chin WW; Ko L
J Biol Chem; 2001 Sep; 276(36):33375-83. PubMed ID: 11443112
[TBL] [Abstract][Full Text] [Related]
40. Molecular and functional aspects of human cysteinyl leukotriene receptors.
Capra V
Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
